1: Fadaly WAA, Mohamed FEA, Nemr MTM, Sayed AM, Khalil RG, Zidan TH. Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: Design, synthesis and in silico studies. Bioorg Chem. 2024 Oct 10;153:107881. doi: 10.1016/j.bioorg.2024.107881. Epub ahead of print. PMID: 39396453.
2: Giovannuzzi S, Nikitjuka A, Angeli A, Smietana M, Massardi ML, Turati M, Ronca R, Bonardi A, Nocentini A, Ferraroni M, Supuran CT, Winum JY. Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: Ex Novo Synthesis, Crystallography, In Silico Studies, and Anti-Melanoma Cell Line Activity. J Med Chem. 2024 Oct 24;67(20):18221-18234. doi: 10.1021/acs.jmedchem.4c01516. Epub 2024 Oct 8. PMID: 39378331.
3: Fujita N, Bondoc A, Simoes S, Ishida J, Taccone MS, Luck A, Srikanthan D, Siddaway R, Levine A, Sabha N, Krumholtz S, Kondo A, Arai H, Smith C, McDonald P, Hawkins C, Dedhar S, Rutka J. Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma. Brain Tumor Pathol. 2024 Oct;41(3-4):117-131. doi: 10.1007/s10014-024-00493-w. Epub 2024 Sep 24. PMID: 39316272.
4: Onyilmaz M, Koca M, Ammara A, Degirmenci M, Supuran CT. Isocoumarins incorporating chalcone moieties act as isoform selective tumor-associated carbonic anhydrase inhibitors. Future Med Chem. 2024 Jul 2;16(13):1347-1355. doi: 10.1080/17568919.2024.2350875. Epub 2024 May 28. PMID: 39109432; PMCID: PMC11318696.
5: Liang Q, Zhang S, Liu J, Zhou X, Syamimi Ariffin N, Wei J, Shi C, Ma X, Zhang Y, Huang R. Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer. Bioorg Chem. 2024 Sep;150:107596. doi: 10.1016/j.bioorg.2024.107596. Epub 2024 Jun 26. PMID: 38941699.
6: Abbas HS, Nossier ES, El-Manawaty MA, El-Bayaa MN. New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity. Sci Rep. 2024 Jun 6;14(1):13028. doi: 10.1038/s41598-024-62864-9. PMID: 38844493; PMCID: PMC11156913.
7: Sharma V, Vats L, Giovannuzzi S, Mohan B, Supuran CT, Sharma PK. In-vitro and in-silico investigations of SLC-0111 hydrazinyl analogs as human carbonic anhydrase I, II, IX, and XII inhibitors. Arch Pharm (Weinheim). 2024 Aug;357(8):e2400157. doi: 10.1002/ardp.202400157. Epub 2024 May 7. PMID: 38713910.
8: Wu S, Zhou X, Li F, Sun W, Zheng Q, Liang D. Novel Anthraquinone-Based Benzenesulfonamide Derivatives and Their Analogues as Potent Human Carbonic Anhydrase Inhibitors with Antitumor Activity: Synthesis, Biological Evaluation, and In Silico Analysis. Int J Mol Sci. 2024 Mar 15;25(6):3348. doi: 10.3390/ijms25063348. PMID: 38542320; PMCID: PMC10969960.
9: Supuran CT. Drug interactions of carbonic anhydrase inhibitors and activators. Expert Opin Drug Metab Toxicol. 2024 Mar;20(3):143-155. doi: 10.1080/17425255.2024.2328152. Epub 2024 Mar 11. PMID: 38450431.
10: Debnath J, Keshamasetthy D, Combs J, Leon K, Vullo D, Chatterjee A, McKenna R, Supuran CT. A comparative study of diaryl urea molecules with and without sulfonamide group on Carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells. Bioorg Chem. 2024 Apr;145:107192. doi: 10.1016/j.bioorg.2024.107192. Epub 2024 Feb 10. PMID: 38382393.
11: Lolak N, Akocak S, Petreni A, Budak Y, Bozgeyik E, Gurdere MB, Ceylan M, Supuran CT. 1,3-Diaryl Triazenes Incorporating Disulfonamides Show Both Antiproliferative Activity and Effective Inhibition of Tumor-associated Carbonic Anhydrases IX and XII. Anticancer Agents Med Chem. 2024;24(10):755-763. doi: 10.2174/0118715206285326240207045249. PMID: 38362678.
12: McDonald PC, Dedhar S. Co-vulnerabilities of inhibiting carbonic anhydrase IX in ferroptosis-mediated tumor cell death. Front Mol Biosci. 2023 Nov 30;10:1327310. doi: 10.3389/fmolb.2023.1327310. PMID: 38099193; PMCID: PMC10720035.
13: Vats L, Arya P, Kumar R, Giovannuzzi S, Raghav N, Supuran CT, Sharma PK. Keto-bridged dual triazole-linked benzenesulfonamides as potent carbonic anhydrase and cathepsin B inhibitors. Future Med Chem. 2023 Oct;15(20):1843-1863. doi: 10.4155/fmc-2023-0201. Epub 2023 Oct 25. PMID: 37877291.
14: Begines P, Bonardi A, Nocentini A, Gratteri P, Giovannuzzi S, Ronca R, Tavani C, Luisa Massardi M, López Ó, Supuran CT. Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies. Bioorg Med Chem. 2023 Oct 30;94:117467. doi: 10.1016/j.bmc.2023.117467. Epub 2023 Sep 7. PMID: 37722299.
15: Andreucci E, Biagioni A, Peri S, Versienti G, Cianchi F, Staderini F, Antonuzzo L, Supuran CT, Olivo E, Pasqualini E, Messerini L, Massi D, Lulli M, Ruzzolini J, Peppicelli S, Bianchini F, Schiavone N, Calorini L, Magnelli L, Papucci L. The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane- derived, and platinum-based drugs. Cancer Lett. 2023 Sep 1;571:216338. doi: 10.1016/j.canlet.2023.216338. Epub 2023 Aug 6. PMID: 37549770.
16: Supuran CT. A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation. Bioorg Med Chem Lett. 2023 Sep 1;93:129411. doi: 10.1016/j.bmcl.2023.129411. Epub 2023 Jul 26. PMID: 37507055.
17: Elsawi AE, Elbadawi MM, Nocentini A, Almahli H, Giovannuzzi S, Shaldam M, Salem R, Ibrahim TM, Abdel-Aziz HA, Supuran CT, Eldehna WM. 1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities. J Med Chem. 2023 Aug 10;66(15):10558-10578. doi: 10.1021/acs.jmedchem.3c00721. Epub 2023 Jul 27. PMID: 37501287.
18: Grajek J, Poleszczuk J. Carbonic Anhydrase IX Suppression Shifts Partial Response to Checkpoint Inhibitors into Complete Tumor Eradication: Model-Based Investigation. Int J Mol Sci. 2023 Jun 13;24(12):10068. doi: 10.3390/ijms241210068. PMID: 37373220; PMCID: PMC10298206.
19: Eldehna WM, Mohammed EE, Al-Ansary GH, Berrino E, Elbadawi MM, Ibrahim TM, Jaballah MY, Al-Rashood ST, Binjubair FA, Celik M, Nocentini A, Elbarbry FA, Sahin F, Abdel-Aziz HA, Supuran CT, Fares M. Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer. Eur J Med Chem. 2023 Oct 5;258:115538. doi: 10.1016/j.ejmech.2023.115538. Epub 2023 Jun 1. PMID: 37321108.
20: Peerzada MN, Vullo D, Paoletti N, Bonardi A, Gratteri P, Supuran CT, Azam A. Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors. ACS Med Chem Lett. 2023 May 8;14(6):810-819. doi: 10.1021/acsmedchemlett.3c00094. PMID: 37312840; PMCID: PMC10258898.